A carregar...
Long-term outcomes of office-based buprenorphine/naloxone maintenance therapy
BACKGROUND: Buprenorphine/naloxone was approved by the FDA for office-based opioid maintenance therapy (OMT), with little long-term follow-up data from actual office-based practice. 18-Month outcome data on the office-based use of buprenorphine/naloxone (bup/nx) and the impact of socioeconomic statu...
Na minha lista:
| Formato: | Artigo |
|---|---|
| Idioma: | en |
| Publicado em: |
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3263699/ https://ncbi.nlm.nih.gov/pubmed/19717249 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2009.07.013 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|